pubmed-article:17311619 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C0019167 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C0524909 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C0456603 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:17311619 | lifeskim:mentions | umls-concept:C0918012 | lld:lifeskim |
pubmed-article:17311619 | pubmed:issue | 2 | lld:pubmed |
pubmed-article:17311619 | pubmed:dateCreated | 2007-2-21 | lld:pubmed |
pubmed-article:17311619 | pubmed:abstractText | Hepatitis B e antigen (HBeAg) seroconversion is an important event in the natural history of chronic hepatitis B virus (HBV) infection. Whether early dynamics of HBeAg index ratio could predict therapeutic endpoint of HBeAg seroconversion in patients receiving lamivudine remains unclear and thus deserves investigation. | lld:pubmed |
pubmed-article:17311619 | pubmed:language | eng | lld:pubmed |
pubmed-article:17311619 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17311619 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:17311619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17311619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17311619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17311619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17311619 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:17311619 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:17311619 | pubmed:month | Mar | lld:pubmed |
pubmed-article:17311619 | pubmed:issn | 1478-3223 | lld:pubmed |
pubmed-article:17311619 | pubmed:author | pubmed-author:KaoJia-HorngJ... | lld:pubmed |
pubmed-article:17311619 | pubmed:author | pubmed-author:ChenDing-Shin... | lld:pubmed |
pubmed-article:17311619 | pubmed:author | pubmed-author:LaiMing-YangM... | lld:pubmed |
pubmed-article:17311619 | pubmed:author | pubmed-author:LiuChun-JenCJ | lld:pubmed |
pubmed-article:17311619 | pubmed:author | pubmed-author:WangChia-ChiC... | lld:pubmed |
pubmed-article:17311619 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:17311619 | pubmed:volume | 27 | lld:pubmed |
pubmed-article:17311619 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:17311619 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:17311619 | pubmed:pagination | 235-9 | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:meshHeading | pubmed-meshheading:17311619... | lld:pubmed |
pubmed-article:17311619 | pubmed:year | 2007 | lld:pubmed |
pubmed-article:17311619 | pubmed:articleTitle | Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients. | lld:pubmed |
pubmed-article:17311619 | pubmed:affiliation | Department of Internal Medicine, Division of Hepatogastroenterology, Buddhist Xindian Tzu Chi General Hospital, Taipei, Taiwan. | lld:pubmed |
pubmed-article:17311619 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:17311619 | lld:pubmed |